US Patent Application 17815514. ANTI-CD46 ANTIBODIES AND METHODS OF USE simplified abstract

ANTI-CD46 ANTIBODIES AND METHODS OF USE

Organization Name

The Regents of the University of California

Inventor(s)

Bin Liu of San Francisco CA (US)

Daniel W. Sherbenou of Denver CO (US)

Blake T. Aftab of Thousand Oaks CA (US)

Yang Su of South San Francisco CA (US)

Christopher R. Behrens of San Francisco CA (US)

ANTI-CD46 ANTIBODIES AND METHODS OF USE - A simplified explanation of the abstract

This abstract first appeared for US patent application 17815514 titled 'ANTI-CD46 ANTIBODIES AND METHODS OF USE

Simplified Explanation

- The patent application describes methods for treating a subject with a specific type of cancer that has a modification at biomarker 1q21. - The treatment involves administering an anti-CD46 antibody to the subject. - The anti-CD46 antibody is given in a therapeutically effective amount. - The purpose of the treatment is to target and treat the cancer characterized by the biomarker modification at 1q21.

Original Abstract Submitted

Disclosed herein are methods of treating a subject having a cancer characterized by a modification at biomarker 1q21, which comprises administering to the subject a therapeutically effective amount of an anti-CD46 antibody.